Filing Flows › Comparisons › KRSA vs STTK
Korsana Biosciences vs Shattuck Labs: KRSA and STTK compared
Korsana Biosciences is the larger company: $1.0M of revenue in its latest quarter (Q4 2025) against $1.0M for Shattuck Labs (Q3 2025). Korsana Biosciences is growing faster (-43% against -67% a year earlier).
Where the money goes: KRSA and STTK
Korsana Biosciences (KRSA) · Q4 2025
Korsana Biosciences, Q4 2025: revenue $1.0M (-43% year over year), operating margin -81.8%, net loss $799K, operating cash flow −$1.6M. The chart follows the revenue to costs, profit and cash.
Shattuck Labs (STTK) · Q3 2025
Shattuck Labs, Q3 2025: revenue $1.0M (-67% year over year), net loss $10.1M, operating cash flow −$8.9M. The chart follows the revenue to costs, profit and cash.
| Korsana Biosciences (KRSA) | Shattuck Labs (STTK) | |
|---|---|---|
| Latest quarter | Q4 2025 | Q3 2025 |
| Revenue | $1.0M | $1.0M |
| Revenue growth, Y/Y | -43% | -67% |
| Operating margin | -81.8% | n/m |
| Net earnings | −$799K | −$10.1M |
| Net margin | -78.0% | — |
| Operating cash flow | −$1.6M | −$8.9M |
Questions
Which is bigger, Korsana Biosciences or Shattuck Labs?
Korsana Biosciences is the larger company: $1.0M of revenue in its latest quarter (Q4 2025) against $1.0M for Shattuck Labs (Q3 2025).
Is Korsana Biosciences or Shattuck Labs growing faster?
Korsana Biosciences is growing faster (-43% against -67% a year earlier).
More: Korsana Biosciences earnings · how Korsana Biosciences makes money · Shattuck Labs earnings · how Shattuck Labs makes money
From the companies' latest 10-Q, 10-K or earnings release (10-K filed Mar 30, 2026; 10-Q filed Nov 6, 2025). Fiscal quarters can end on different dates. Not investment advice.